Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia

Documenti analoghi

• Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
  di: Eesha A. Zaheer, et al.
  Pubblicazione: (2026)
• Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
  di: Ashley C. Holland, et al.
  Pubblicazione: (2025)
• Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
  di: Reena Pabari, et al.
  Pubblicazione: (2025)
• Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
  di: Andrew E. Place, et al.
  Pubblicazione: (2025)
• Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
  di: Kellee N. Parker, et al.
  Pubblicazione: (2026)